✦ LIBER ✦

Favorable results using methotrexate in the treatment of patients with ankylosing spondylitis

✍ Scribed by Richard P. Handler

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 135 KB
Volume: 32
Category: Article
ISSN: 0004-3591
DOI: 10.1002/anr.1780320221

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reintroduction of etanercept during trea

Reintroduction of etanercept during treatment of cutaneousMycobacterium marinuminfection in a patient with ankylosing spondylitis

✍ Dare, Jason A. ;Jahan, Shormi ;Hiatt, Kim ;Torralba, Karina D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Six-month results of a double-blind, pla

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

✍ J. Brandt; A. Khariouzov; J. Listing; H. Haibel; H. Sörensen; L. Grassnickel; M. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Objective There is increasing evidence that tumor necrosis factor α (TNFα) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. This study was designed to investigate the efficacy of anti‐TNFα therapy with etanercept, a 75‐kd recepto

Validation exercise of the Ankylosing Sp

Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics

✍ Stone, Millicent A. ;Inman, Robert D. ;Wright, James G. ;Maetzel, Andreas 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Abstract ## Objectives To define what expert clinicians consider a dramatic response in ankylosing spondylitis (AS) patients treated with biologic therapies based on patient and physician assessments of global disease activity. To compare this expert clinician‐derived criteria to the Ankylosing

Evaluation and validation of the patient

Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis

✍ Maksymowych, Walter P. ;Richardson, Rhonda ;Mallon, Catherine ;van der Heijde, D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Abstract ## Objective The Patient Acceptable Symptom State (PASS) constitutes an absolute level of patient well‐being and represents an ambitious target for disease management. We explored contributors to PASS, validated the PASS concept, and assessed thresholds of self‐reported outcomes below

The influence of peripheral arthritis on

The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index

✍ Heuft-Dorenbosch, Liesbeth ;Van Tubergen, Astrid ;Spoorenberg, Anneke ;Landewé, 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Objectives: To assess the differences in disease activity as measured by the bath ankylosing spondylitis disease activity index (basdai) between patients with and without peripheral arthritis/enthesitis. to investigate whether scores on the basdai change by omitting the 2 questions on peripheral

Efficacy and safety of infliximab in pat

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)

✍ Désirée van der Heijde; Ben Dijkmans; Piet Geusens; Joachim Sieper; Kimberly DeW 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views